GB0300295D0 - Use - Google Patents

Use

Info

Publication number
GB0300295D0
GB0300295D0 GB0300295A GB0300295A GB0300295D0 GB 0300295 D0 GB0300295 D0 GB 0300295D0 GB 0300295 A GB0300295 A GB 0300295A GB 0300295 A GB0300295 A GB 0300295A GB 0300295 D0 GB0300295 D0 GB 0300295D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0300295A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB0300295A priority Critical patent/GB0300295D0/en
Publication of GB0300295D0 publication Critical patent/GB0300295D0/en
Priority to PCT/GB2003/001076 priority patent/WO2003077999A1/en
Priority to CNA038109999A priority patent/CN1652844A/en
Priority to EP03712345A priority patent/EP1485168A1/en
Priority to JP2003576050A priority patent/JP2005526086A/en
Priority to AU2003216810A priority patent/AU2003216810A1/en
Priority to US10/507,883 priority patent/US20050164976A1/en
Priority to MXPA04009012A priority patent/MXPA04009012A/en
Ceased legal-status Critical Current

Links

GB0300295A 2002-03-15 2003-01-07 Use Ceased GB0300295D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0300295A GB0300295D0 (en) 2003-01-07 2003-01-07 Use
PCT/GB2003/001076 WO2003077999A1 (en) 2002-03-15 2003-03-14 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer
CNA038109999A CN1652844A (en) 2002-03-15 2003-03-14 Combination of a CDK inhibitor and 5-FU for the treatment of cancer
EP03712345A EP1485168A1 (en) 2002-03-15 2003-03-14 Combination of a cdk inhibitor and 5-fu for the treatment of cancer
JP2003576050A JP2005526086A (en) 2002-03-15 2003-03-14 Combination of CDK inhibitor and 5-FU for the treatment of cancer
AU2003216810A AU2003216810A1 (en) 2002-03-15 2003-03-14 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer
US10/507,883 US20050164976A1 (en) 2002-03-15 2003-03-14 Combination of a cdk inhibitor and 5-fu for the tratment of cancer
MXPA04009012A MXPA04009012A (en) 2002-03-15 2003-03-14 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0300295A GB0300295D0 (en) 2003-01-07 2003-01-07 Use

Publications (1)

Publication Number Publication Date
GB0300295D0 true GB0300295D0 (en) 2003-02-05

Family

ID=9950764

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0300295A Ceased GB0300295D0 (en) 2002-03-15 2003-01-07 Use

Country Status (1)

Country Link
GB (1) GB0300295D0 (en)

Similar Documents

Publication Publication Date Title
EP1615948A4 (en) Immuno-amplification
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
EP1635758A4 (en) Orthodynamic rehabilitator
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE602004030538D1 (en) Präzisionssubstratlagerbehälter
EP1629178A4 (en) Rockbolt
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
DE602004027010D1 (en) Thermotherapiehülle
DE502004003476D1 (en) Standfuss
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
GB0315259D0 (en) Use
DE502004004146D1 (en) Pyrazolverbindungen
DK1665437T3 (en) Reformeringsmodul
DE60333037D1 (en) Laser-radar
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004011343D1 (en) Rotorspinnmaschine
DE602004020525D1 (en) Imidazolderivate
DE502004012153D1 (en) Rotorspinnmaschine
GB0302741D0 (en) Use
DE10394343D2 (en) Berührungslose biometrische erkennung
GB0313913D0 (en) New use
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
DE602004008281D1 (en) Avermectin-b1-monosaccharidderivative

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)